Literature DB >> 3827334

Anaemia in juvenile chronic arthritis: serum inhibition of normal erythropoiesis in vitro.

P J Prouse, A R Harvey, B Bonner, C D Reid, B M Ansell, M Gumpel.   

Abstract

Serum from patients with juvenile chronic arthritis (JCA) was shown to inhibit colony formation by normal erythropoietic progenitor cells cultured in vitro. The inhibition was proportional to the degree of anaemia and to certain indices of activity of the arthritis and systemic disease. It occurred in a dose dependent manner with increasing serum concentration and was independent of previous blood transfusion or administered drugs. Erythropoietic progenitor cells from the bone marrows of anaemic patients with JCA showed normal requirements for accessory cells (T lymphocytes and macrophages) in culture, and autologous accessory cells were not deficient in providing normal growth requirements.

Entities:  

Mesh:

Year:  1987        PMID: 3827334      PMCID: PMC1002078          DOI: 10.1136/ard.46.2.127

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  25 in total

1.  Modulation of hemopoiesis by prostaglandins.

Authors:  J Kurland; M A Moore
Journal:  Exp Hematol       Date:  1977-09       Impact factor: 3.084

2.  Simplified procedure for the separation of human T and non-T cells.

Authors:  F Gmelig-Meyling; R E Ballieux
Journal:  Vox Sang       Date:  1977-07       Impact factor: 2.144

Review 3.  The anaemia of chronic disorders.

Authors:  G E Cartwright; G R Lee
Journal:  Br J Haematol       Date:  1971-08       Impact factor: 6.998

4.  Ferritin synthesis in inflammation. I. Pathogenesis of impaired iron release.

Authors:  A M Konijn; C Hershko
Journal:  Br J Haematol       Date:  1977-09       Impact factor: 6.998

5.  Cell-cell interaction in erythropoiesis. Role of human monocytes.

Authors:  J J Rinehart; E D Zanjani; B Nomdedeu; B J Gormus; M E Kaplan
Journal:  J Clin Invest       Date:  1978-11       Impact factor: 14.808

6.  Heberden Oration, 1977. Chronic arthritis in childhood.

Authors:  B M Ansell
Journal:  Ann Rheum Dis       Date:  1978-04       Impact factor: 19.103

7.  Erythropoiesis and mean red-cell lifespan in normal subjects and in patients with the anaemia of active rheumatoid arthritis.

Authors:  H J Dinant; C E de Maat
Journal:  Br J Haematol       Date:  1978-07       Impact factor: 6.998

8.  Anemia in patients with juvenile rheumatoid arthritis.

Authors:  M A Koerper; D A Stempel; P R Dallman
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

9.  The mechanism of the anaemia in rheumatoid arthritis: effects of bone marrow adherent cells and of serum on in-vitro erythropoiesis.

Authors:  C D Reid; P J Prouse; L C Baptista; J M Gumpel; I Chanarin
Journal:  Br J Haematol       Date:  1984-12       Impact factor: 6.998

10.  Characterization of an erythroid precursor cell of high proliferative capacity in normal human peripheral blood.

Authors:  B J Clarke; D Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

View more
  4 in total

1.  Pure red cell aplasia in systemic onset juvenile idiopathic arthritis.

Authors:  Priya Sreenivasan; N S Mani
Journal:  Indian J Hematol Blood Transfus       Date:  2011-06-22       Impact factor: 0.900

2.  Anaemia of chronic disease in rheumatoid arthritis: effect of the blunted response to erythropoietin and of interleukin 1 production by marrow macrophages.

Authors:  M A Smith; S M Knight; P J Maddison; J G Smith
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  Mechanism of anaemia in rheumatoid arthritis: demonstration of raised interleukin 1 beta concentrations in anaemic patients and of interleukin 1 mediated suppression of normal erythropoiesis and proliferation of human erythroleukaemia (HEL) cells in vitro.

Authors:  C P Maury; L C Andersson; A M Teppo; S Partanen; E Juvonen
Journal:  Ann Rheum Dis       Date:  1988-12       Impact factor: 19.103

4.  Anaemia in juvenile chronic arthritis.

Authors:  B Kirel; S Yetgin; U Saatci; S Ozen; A Bakkaloglu; N Besbas
Journal:  Clin Rheumatol       Date:  1996-05       Impact factor: 2.980

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.